AstraZeneca Shares Rise After Lung Drug Hits Goals in Late-Stage Trials

4 days ago 5

Tozorakimab met the superior extremity successful 2 late-stage objective trials, reducing the complaint astatine which patients’ symptoms worsened, the institution said.

Read Entire Article

AstraZeneca Shares Rise After Lung Drug Hits Goals in Late-Stage Trials

Related

Want to renew healthy eating habits? Greek monks have a spri...

Big drugmakers aren’t doing as big deals as they had, mostly...

Supreme Court Rejects Colorado Law Banning ‘Conversion Thera...

FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths

Novo Nordisk Launches Discounted Subscription Program for We...

Evacuated from Gaza as newborns, a group of Palestinian todd...

Popular

The Tiny Country Behind Some of Soccer’s Biggest Stars Is on...

Who Will Yell at the Robot Umpires?

Nestlé says 413,793 KitKat candy bars stolen en route from I...

The Best Fitness Gear to Achieve Your Goals, According to Pr...

Call out to volunteers to take part in bug survey